ArticleDiabetes, obesity & metabolism2026

GLP-1 Receptor Agonist Therapy for Obesity Under Japan's Optimal Use Guideline: A Prospective Real-World Study of Lifestyle Pre-Treatment, Time-Limited Treatment Cap, and Post-Cessation Regain.

Susumu Inamine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.